Similar articles

• COX-2 inhibitors.

  Tustin T. Tustin T. Lancet. 1999 Apr 24;353(9162):1439; author reply 1440. doi: 10.1016/S0140-6736(99)00074-4. Lancet. 1999. PMID: 10227242 No abstract available.
• [Selective inhibitors of cyclooxygenase-2: new perspectives of human diseases management].

  Nasonov EL, Tsvetkova ES, Tov NL. Nasonov EL, et al. Ter Arkh. 1998;70(5):8-14. Ter Arkh. 1998. PMID: 9644734 Russian. No abstract available.
• [COX-2 inhibitors: current status and outlook].

  Dannhardt G, Hahn L. Dannhardt G, et al. Pharm Unserer Zeit. 2000 Mar;29(2):100-6. doi: 10.1002/(SICI)1615-1003(200002)29:2<100::AID-PAUZ100>3.0.CO;2-V. Pharm Unserer Zeit. 2000. PMID: 10763335 Review. German. No abstract available.
• COX-1 and COX-2 inhibition: current status and future perspective.

  Greyn J, Lauwers MH, Vanlersberghe C, Camu F. Greyn J, et al. Acta Anaesthesiol Belg. 1998;49(3):175-83. Acta Anaesthesiol Belg. 1998. PMID: 9844704 Review. No abstract available.
• [COX-1 and COX-2: functions and pharmacological effects].

  Hinz B, Brune K. Hinz B, et al. Pharm Unserer Zeit. 1999 Jan;28(1):21-9. Pharm Unserer Zeit. 1999. PMID: 10078026 Review. German. No abstract available.